New indication area in intersphincteric resection: transanal total mesorectal excision combined with intersphincteric resection.

Publication Year: 2023

DOI:
10.1093/gastro/goad007

PMCID:
PMC9995089

PMID:
36911143

Journal Information

Full Title: Gastroenterol Rep (Oxf)

Abbreviation: Gastroenterol Rep (Oxf)

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology & Hepatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of Interest None declared. Authors’ reply Zhi-Hang Liu and Liang Kang Department of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P. R. China We are glad that many doctors share our concern about the treatment of low rectal cancer. Under the premise of ensuring the survival of patients, we have been seeking for many years to preserve the anus of patients with low rectal cancer, in order to improve the quality of life of patients. In this study, through preoperative data matching, some patients who could only receive abdominoperineal resection (APR) surgery received transanal total mesorectal excision (taTME) + intersphincteric resection (ISR) surgery under the new concept. The seemingly bold approach reflected our surgical team's confidence in the surgical concept and technology. The following are our answers for the questions. Question 1. How many patients had tumor invasion in the intersphincteric space? Answer: After matching, 100 patients in each group were enrolled in the subsequent study. We found that 66 patients in the laparoscopic abdominoperineal resection (laAPR) group had tumor invasion in the intersphincteric space compared with 64 patients in the taTME + ISR group. Question 2. Is there a relationship between patients who developed LR and tumor invasion in the intersphincteric area? Could this relationship be checked with univariate and multivariate analysis? Answer: During the follow-up period, seven patients in each group developed LR. Meanwhile, in both groups of patients with LR, four patients were found to have tumor-invaded intersphincteric space. Therefore, we do not find a relationship between patients who developed LR and tumor invasion in the intersphincteric space. Question 3. What kind of surgeries were performed in patients who developed LR? Answer: If patients had only LR, local resection was recommended by doctors. When patients had LR and distant metastasis, many patients were only willing to accept ostomy surgery and chemotherapy, or even only chemotherapy, rather than surgical treatment. Question 4. This project was designed as a propensity score-matched cohort study. Although the demographic and clinical characteristics of the two groups of patients showed a homogeneous distribution, the fact that lymphovascular invasion, perineal invasion, and extramural vascular invasion, which have an impact on poor prognosis, were not examined creates a question mark. Answer: In order to balance the differences between groups, preoperative data were usually used for matching, whether in our retrospective or prospective studies. At the same time, under similar preoperative conditions, we could compare the quality of surgical excision between the two groups. For factors such as lymphovascular invasion, perineal invasion, and extramural vascular invasion, the previous imaging methods were not clear enough. In most cases, pathological state could only be known from the surgical specimen. Therefore, when conducting matching studies, we still consider gender, age, tumor size, preoperative TNM stage, and so on. Our team will continue to publish research on the treatment of rectal cancer. Please pay attention to our subsequent studies. I hope that we can keep in touch with readers and make progress together."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025